The effects of finasteride on hematuria associated with benign prostatic hyperplasia: a preliminary report.
OBJECTIVE
The efficacy of finasteride was assessed in the treatment of gross hematuria associated with benign prostatic hyperplasia (BPH).


METHODS
A retrospective review was done of 18 patients who had been placed on finasteride (5 mg . daily) for the treatment of gross hematuria associated with BPH. A hematuria grading system was devised.


RESULTS
Of the 12 patients with longer than 3 months of followup (mean 14) 11 improved according to the grade of hematuria after finasteride therapy.


CONCLUSIONS
Finasteride is effective in treating hematuria associated with BPH. This finding is especially relevant for patients with multiple medical problems and anesthetic risks.
Puchner
P J
PJ
Department of Urology, Columbia University College of Physicians and Surgeons, New York, New York, USA.
Miller
M I
MI
D000368:Aged; D000369:Aged, 80 and over; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D018120:Finasteride / Q000627:therapeutic use*; D006417:Hematuria / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000150:complications*; D012189:Retrospective Studies
D004791:Enzyme Inhibitors; D018120:Finasteride